Zacks Investment Research
17 Aug 2026, 18:51 UTC · 11w ago
QDEL Rallies 31.7% in Three Months: Can the Stock Keep Climbing Higher?
Impact · against what's priced in
QuidelOrtho's outlook is significantly weakened by a drastic reduction in 2026 earnings and revenue guidance, primarily driven by pricing headwinds in China. While operational cost-cutting is improving margins, it is insufficient to offset the top-line contraction and lowered EPS expectations.
- QDEL−0.50
No priced-in read yet
- In context
The company slashed 2026 adjusted earnings guidance from $1.80-$2.00 to 65-90 cents per share and reduced revenue guidance to $2.52-$2.60 billion. These cuts are compounded by a 23.3% drop in China revenues, though partially mitigated by a 21% increase in adjusted EBITDA.
Read from the article alone
